BioForce NanoSciences appoints interim CEO, adds director and advisory board members

BIOFORCE NANOSCIENCES HOLDINGS, INC.

Richard Kaiser appointed interim CEO on June 17, 2026; he remains CFO, Secretary, and Director.
Scott Mager appointed General Counsel on May 19, 2026, and Director on June 15, 2026.
Advisory Board established May 19, 2026; Stuart Yarbrough and Edward Mathias appointed for 3-year terms ending May 19, 2029.
Yarbrough is CPA with 20+ years at Ernst & Young and BDO; Mathias is senior advisor to Carlyle Group.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.